| Dataset | DrugBank Drug Targets |
| Category | physical interactions |
| Type | drug |
| Description | A sulfonamide obtained by formal condensation of the sulfonic acid group of 4-[(3-methoxy-4-methylbenzoyl)amino]benzenesulfonic acid with the primary aromatic amino group of N-(3,5-dimethoxyphenyl)quinoxaline-2,3-diamine. A dual PI3K/mTOR inhibitor used in cancer treatment. (Chemical Entities of Biological Interest Ontology, CHEBI_71958) |
| External Link | http://www.drugbank.ca/drugs/DB05241 |
| Similar Terms | |
| Downloads & Tools |
5 interacting proteins for the XL765 drug from the curated DrugBank Drug Targets dataset.
| Symbol | Name |
|---|---|
| MTOR | mechanistic target of rapamycin (serine/threonine kinase) |
| PIK3CA | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
| PIK3CB | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta |
| PIK3CD | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
| PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
